Facebook Pixel
Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited (DCAL)

196.71

INR
-12.21(-5.84%)
As of April 30, 2025 7:28:00 AM

About Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Ltd. is a prominent player in the global pharmaceutical and chemical manufacturing industry. As an integrated outsourcing partner, the company provides a broad range of services that support the entire lifecycle of a product. Its primary function is to offer high-quality contract research and manufacturing services (CRAMS) which cater to the pharmaceutical, biopharmaceutical, and healthcare sectors. Dishman Carbogen Amcis specializes in developing active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals that are essential in drug formulation and production. The company's extensive expertise and cutting-edge facilities allow it to support drug development from discovery and research stages through to clinical trials and commercialization. By enabling pharmaceutical companies to streamline their manufacturing processes, Dishman Carbogen Amcis plays a critical role in enhancing efficiency and reducing time-to-market for new medications. Headquartered in India, with a global footprint, the company is integral to the advancement of the pharmaceutical supply chain, impacting healthcare innovation and accessibility worldwide.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
1.27
Operating MarginLast 12 months
9.99
+4.799643674453609% quarterly YoY
Market Cap
3355.53 CrINR
Employees
1132
CEO
Dr. Himani S. Dhotre
Website